Valuation: Cipla Limited

Market Cap 1,17100Cr 1.23TCr 1.06TCr 994.23Cr 904.2Cr 1.7TCr 1.73TCr 12TCr 4.55TCr 59TCr 4.6TCr 4.5TCr 1,94900Cr P/E 2027 *
28.2x
P/E 2028 * 22.8x
Enterprise Value 1,06500Cr 1.11TCr 962.23Cr 904.2Cr 822.32Cr 1.55TCr 1.57TCr 11TCr 4.14TCr 53TCr 4.18TCr 4.09TCr 1,77300Cr EV / Sales 2027 *
3.44x
EV / Sales 2028 * 2.99x
Free-Float
68.87%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day-1.12%
1 week-2.32%
Current month-2.68%
1 month+1.06%
3 months+0.53%
6 months+6.68%
Current year-5.13%
1 week 1,432.6
Extreme 1432.6
1,474.3
1 month 1,366.1
Extreme 1366.1
1,491.2
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%-2.32%-8.40%+15.53% 1.23TCr
-0.87%-1.59%+17.20%+67.15% 4.84TCr
+0.37%-3.90%+52.32%+119.77% 3.97TCr
+0.68%+2.20%+15.92%+77.34% 1.18TCr
-0.58%-0.77%+29.90%+141.59% 906.17Cr
+1.56%+5.52%+23.69%+41.92% 756.57Cr
-1.21%-0.76%+42.21%-13.93% 717.59Cr
+0.10%+3.09%+17.58%+197.82% 684.21Cr
-2.51%-3.14%-30.53%+23.06% 576.86Cr
+0.96%+5.73%+37.76%+108.08% 479.87Cr
Average -0.26%+1.73%+19.77%+77.83% 1.53TCr
Weighted average by Cap. -0.29%+1.10%+25.25%+82.25%

Financials

2027 *2028 *
Net sales 31TCr 324.08Cr 279.9Cr 263.02Cr 239.21Cr 449.73Cr 457.14Cr 3.08TCr 1.2TCr 16TCr 1.22TCr 1.19TCr 52TCr 35TCr 363.2Cr 313.69Cr 294.78Cr 268.08Cr 504.02Cr 512.33Cr 3.45TCr 1.35TCr 17TCr 1.36TCr 1.33TCr 58TCr
Net income 4.14TCr 43Cr 37Cr 35Cr 32Cr 60Cr 61Cr 411.23Cr 160.79Cr 2.07TCr 162.36Cr 158.83Cr 6.88TCr 5.14TCr 54Cr 46Cr 44Cr 40Cr 75Cr 76Cr 511.37Cr 199.94Cr 2.57TCr 201.89Cr 197.51Cr 8.56TCr
Net Debt -11TCr -110.93Cr -96Cr -90Cr -82Cr -153.94Cr -156.48Cr -1.05TCr -412.46Cr -5.31TCr -416.48Cr -407.44Cr -18TCr -13TCr -137.46Cr -118.73Cr -111.57Cr -101.46Cr -190.76Cr -193.9Cr -1.31TCr -511.11Cr -6.58TCr -516.1Cr -504.9Cr -22TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
17/26/17 1,425.70 -1.68% 1,26,418
14/26/14 ₹1,450.00 -0.60% 7,84,917
13/26/13 ₹1,458.80 -0.29% 4,40,742
12/26/12 ₹1,463.00 0.00% 6,21,021
11/26/11 ₹1,463.00 -0.32% 9,58,909
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,450.00INR
Average target price
1,509.08INR
Spread / Average Target
+4.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock